We’re thrilled to share that ODPRN Co-Director @mina-t.bsky.social has been promoted to Associate Professor at @uoftpharmacy.bsky.social! We are incredibly proud to have him on our team and look forward to his continued leadership as he takes on this exciting new role. 🎉 🎉

Join the ODPRN Virtual Town Hall on Pharmacist Prescribing for Minor Ailments in Ontario! 📅 June 17, 2025 ⏰ 12:00 – 1:30 pm EDT Share your experiences & ideas to improve services and access. Facilitator @mina-t.bsky.social will be there to answer questions. odprn.ca/town-halls/

ODPRN's Director of Pharmacy Practice and Pharmaceutical Policy, @mina-t.bsky.social, speaks with @globalnews.ca.web.brid.gy about tariffs on prescription drugs in Canada. ca.news.yahoo.com/health-matte...

#ICESOntario scientist Dr. Mina Tadrous @mina-t.bsky.social discusses how tariffs would affect Canadian-made drugs on @globalnews.ca.web.brid.gy

We’re analyzing (early teaser) where the U.S. really gets its final drug dosages from—and early data is eye-opening. This is why drug supply chains must be protected from strain—including #tariffs. Global thinking is essential here.

Trump’s proposed tariffs likely to cause shortages of Canadian-made drugs in U.S., study says. 25% tariffs would lead to an increased cost of US$750-million for American buyers, research says, by @hannay.bsky.social www.theglobeandmail.com/business/eco... via @theglobeandmail.com

A little break from doom scrolling courtesy of PhD Student Martin Ho and how he sees my work at the pharmacy. @uoftpharmacy.bsky.social

🆕! Talk of tariffs is leaving many confused about how they'll affect drug prices & supply in the US. In JAMA, experts @mina-t.bsky.social & Dr. Katie Suda & team describe how tariffs on Canadian 💊 will impact US patients & payers. jamanetwork.com/journals/jam...

Tariffs on pharmaceutical drugs manufactured in Canada could raise US costs by $750 million and strain supply chains, with brand-name drugs likely absorbing short-term increases. https://ja.ma/4l3QSbv

"Americans will feel the pain in their medicine chest when their antibiotics, vaccines, and prescriptions suddenly jump in cost by 25 percent" - @mina-t.bsky.social @edmontonjournal.bsky.social edmontonjournal.com/news/world/t...

In an interview with @cbcnews-rss.bsky.social, @mina-t.bsky.social explains the impact of potential tariffs on medical equipment and drugs. www.cbc.ca/player/play/...

This study examined @WHO recommended National Action Plan post-implementation changes in antibiotic utilization among 38 countries. Authors include @mina-t.bsky.social & CP3's Tate Miner, @CallawayKim4, & @Sudamonas Presented @IDWeekmtg & pub in @OFIDJournal academic.oup.com/ofid/article...

Join the ODPRN Virtual Town Hall on Pharmacist Prescribing for Minor Ailments in Ontario! 📅 March 4, 2025 ⏰ 1:00 – 2:30 pm EDT Share your experiences & ideas to improve services and access. Facilitator @mina-t.bsky.social will be there to answer questions. odprn.ca/town-halls/

This study identifies inconsistent evaluation practices of large language models (LLMs) in health care, finding a lack of standardized frameworks and limited use of real patient data. ja.ma/40WLHSt #MedSky

Statistical methods are the backbone of health research. #ICESOntario senior core scientist Dr. Peter Austin shares how his work is helping shape health outcomes in Ontario and offers some key advice for future statisticians. Read more: www.ices.on.ca/story...

Government of Canada signs bilateral agreement with Ontario for Drugs for Rare Diseases. “Ontario is making it easier and faster for people of all ages, living with rare diseases to connect to the treatment they need" - Sylvia Jones www.canada.ca/en/health-ca...

Merry Orthodox Christmas to everyone celebrating today!

Excited to see Health Canada's proposed Critical Drug List (CVDL), a step in addressing drug shortages. Our tool, balancing clinical & supply chain risks, was cited as a vital component in shaping this. Learn more: www.canada.ca/en/health-ca... #DrugShortages

Health Canada published their proposed regs to address shortages. This includes mandatory safety stocks and shortage plans. This includes the list of drugs affected. 🔗 canadagazette.gc.ca/rp-pr/p1/202... #supplychain #drugshortages #pharmaceuticals #healthpolicy

Happy Festivus!! We begin with the traditional airing of grievances. I'll start (same again)-> journals that make you jump through hoops to submit with their format/style/extra parts then quickly desk-reject your paper! #HappyFestivus #phdchat #healthresearch

The latest edition of ODPRN's Quarterly Newsletter is now available on LinkedIn! Here’s what ODPRN has been up to this past Fall and what’s coming up this Winter! www.linkedin.com/posts/ontari...

Watch our updated top 15 outpatient drug purchases in 🇨🇦 From our updated forecast paper! canjhealthtechnol.ca/index.php/cj...

A new study finds that total estimated drug purchases in #Canada for 2023 were ~13.7% higher than in 2022, reflecting accelerated growth likely driven by increased use of new diabetes and obesity treatments. Learn more at: odprn.ca/research/pub... @mina-t.bsky.social

🚨 Join Our Team! 🚨 We’re hiring a Research Analyst at UofT's Leslie Dan Faculty of Pharmacy! Work on impactful projects in pharmacoepi & health services research with ICES data. 📍 Toronto, ON 💻 Apply: jobs.utoronto.ca/job/Toronto-Re… Please RT!#Hiringn#Pharmacoepip#TorontoJobsbs

Though the US spends more than Canada on 💊purchases, that doesn't translate to better access. Read more @amcporg www.jmcp.org/doi/10.18553... @mina-t.bsky.social @pittgim.bsky.social @pittdeptofmed.bsky.social

National Treasure.

Americans pay more, do they get more? Per capita spending on drugs in the United States is 2x that of Canada. @mina-t.bsky.social and colleagues look at availability across both countries, and observe similar access to important drugs in both countries. www.jmcp.org/doi/10.18553...

🚨 New paper alert! Does paying more for drugs in the US mean you’re getting more valuable drugs? The US gets more drugs and gets them sooner, but is the value there? @pittcp3.bsky.social 👉 Read it here: www.jmcp.org/doi/10.18553... #healthpolicy #DrugPricing

Reductions in prices associated with the Medicare Drug Price Negotiation Program differed widely across the 10 drugs. The negotiated prices of all products but 1 remained above list prices in peer countries. ja.ma/3B9rsXF

🆕 in JAMA: study comparing drug shortages in the US & Canada, by team including CP3's @CallawayKim4 @walidgellad & @Sudamonas. They found drug-related supply chain issue reports were 40% less likely to result in meaningful drug shortages in Canada compared with US. jamanetwork.com/journals/jam...